Literature DB >> 16044441

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.

Takuya Matsunaga1, Kazuyuki Murase, Makoto Yoshida, Akihito Fujimi, Satoshi Iyama, Kageaki Kuribayashi, Tsutomu Sato, Katsuhisa Kogawa, Yasuo Hirayama, Sumio Sakamaki, Kyuhei Kohda, Yoshiro Niitsu.   

Abstract

We report a patient with adult T-cell lymphoma who developed acute myeloid leukemia (AML) after allogeneic cord blood transplantation (CBT). Fluorescence in situ hybridization (FISH) studies and molecular analysis using short tandem repeat (STR) sequences proved the AML to be of donor origin. Although 25 cases of donor cell leukemia (DCL) occurring after allogeneic bone marrow transplantation have previously been reported, there have been no reports of DCL after CBT. This case is the first-reported DCL patient after CBT. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2005        PMID： 16044441     DOI： 10.1002/ajh.20349

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  18 in total

1.  Donor-derived second hematologic malignancies after cord blood transplantation.

Authors:  Karen K Ballen; Corey Cutler; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal C Attar; Yi-Bin Chen; Richard L Haspel; Deborah Liney; John Koreth; Vincent Ho; Edwin P Alyea; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-21       Impact factor: 5.742

2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 3.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

Review 4.  Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.

Authors:  Jennifer Crow; Kenneth Youens; Susan Michalowski; Gail Perrine; Cassandra Emhart; Felicia Johnson; Amy Gerling; Joanne Kurtzberg; Barbara K Goodman; Siby Sebastian; Catherine W Rehder; Michael B Datto
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

5.  Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Authors:  Robbie G Majzner; Huzefa Mogri; Ravi Varadhan; Patrick Brown; Kenneth R Cooke; Javier Bolaños-Meade; Lode Swinnen; Jennifer Kanakry; Leo Luznik; Richard J Jones; Ephraim Fuchs; Rich Ambinder; Yvette Kasamon; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-03       Impact factor: 5.742

6.  Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy.

Authors:  Ibrahim Aldoss; Joo Y Song; Peter T Curtin; Stephen J Forman
Journal:  Blood Adv       Date:  2020-10-13

Review 7.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

8.  Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.

Authors:  Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro; Keiichi Nemoto
Journal:  Int J Hematol       Date:  2009-08-20       Impact factor: 2.490

Review 10.  Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review.

Authors:  Makoto Murata; Yuichi Ishikawa; Haruhiko Ohashi; Seitaro Terakura; Kazutaka Ozeki; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-05-10       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.